z-logo
Premium
Liquid chromatography‐mass spectrometric method for determination of the non‐imidazole H 3 ‐receptor antagonist UPR1056 in rat plasma
Author(s) -
Vacondio Federica,
Silva Claudia,
Morini Giovanni,
Bordi Fabrizio,
Flammini Lisa,
Barocelli Elisabetta,
Mor Marco
Publication year - 2011
Publication title -
journal of separation science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.72
H-Index - 102
eISSN - 1615-9314
pISSN - 1615-9306
DOI - 10.1002/jssc.201000845
Subject(s) - chemistry , chromatography , protein precipitation , detection limit , trifluoroacetic acid , imidazole , high performance liquid chromatography , mass spectrometry , electrospray , selected reaction monitoring , antagonist , acetonitrile , analytical chemistry (journal) , tandem mass spectrometry , receptor , stereochemistry , biochemistry
The non‐imidazole H3 receptor antagonist UPR1056 was dosed in plasma samples from rats individually administered with a single i.p. dose of 1.25 mg/kg by means of a newly validated HPLC‐MS method. UPR1056 was extracted from rat plasma by protein precipitation with acetonitrile and was separated by linear gradient elution, employing water and methanol both additioned with 0.05% trifluoroacetic acid as mobile phases. UPR1056 was detected in MS using an electrospray ion source operating in positive ion mode. Acquisition was performed in single ion monitoring mode at m/z =349.3. The method was validated over the concentration range of 17.43–1743 ng/mL (50–5000 pmol/mL). Within‐ and between‐run precision for the low, mid and high quality controls (QC) levels were 6.75% or less and accuracy ranged from 95.8 to 107.6%. The lower limit of quantification was 17.43 ng/mL. The analysis of the time course of UPR1056 concentrations over the 24‐h period revealed a C max of 1147 ng/mL after 2 h from peripheral administration of the non‐imidazole H 3 ‐receptor antagonist, with a prolonged elimination half‐life of over 9 h.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here